Sonal Paul, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in gastrointestinal cancers.
“I’m excited to join an institution of GW’s caliber, where I can integrate patient education and overcoming barriers to care in my daily practice,” said Paul. “I’m committed to empowering my patients with the necessary knowledge to thoroughly understand their diagnoses and treatment options.”
Dr. Paul brings a wealth of experience to GW, having served as a medical hematologist-oncologist at LifeBridge Health in Baltimore, MD. Her journey includes a significant role as the Chief Hematology-Oncology Fellow at New York-Presbyterian Brooklyn Methodist Hospital – Weill Cornell Medicine, where she also completed her Internal Medicine residency. Dr. Paul further honed her skills at the Memorial Sloan-Kettering Cancer Center in New York.
A native of Maryland, Dr. Paul earned her Bachelor of Science degree in Biological Sciences at the University of Maryland, Baltimore County, and graduated with honors from Ross University School of Medicine.
Dr. Paul’s research, as a principal investigator for numerous clinical trials, is at the forefront of advancing the understanding and treatment of gastrointestinal cancers. Her published papers, including the role of immune checkpoint inhibitors in gastrointestinal malignancies (Journal of Clinical Medicine), the genomic landscape of SMARCA4 alterations in lung cancer patients (Clinical Cancer Research), and the efficacy of convalescent plasma in hospitalized COVID-19 patients (Nature Medicine), have significantly contributed to the field.
“I’m looking forward to furthering my research here at GW, engaging patients in novel treatment protocols, and partnering with them to improve their outcomes,” said Paul, “and GW Cancer Center is the perfect place to put all of these elements into practice.”
